Prelude Capital Management’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,012
Closed -$249K 1365
2025
Q3
$249K Buy
25,012
+1,706
+7% +$18.9K 0.02% 829
2025
Q2
$211K Buy
23,306
+6,225
+36% +$40.6K 0.02% 793
2025
Q1
$110K Buy
+17,081
New +$152K 0.01% 1029
2024
Q1
Sell
-12,325
Closed -$135K 1370
2023
Q4
$135K Buy
+12,325
New +$121K 0.01% 1002
2023
Q2
Sell
-33,485
Closed -$437K 1195
2023
Q1
$437K Buy
33,485
+15,279
+84% +$125K 0.03% 508
2022
Q4
$198K Buy
+18,206
New +$224K 0.01% 974
2022
Q3
Sell
-18,150
Closed -$268K 1660
2022
Q2
$141K Buy
+18,150
New +$171K ﹤0.01% 1364

Other funds holding ENVX

Prelude Capital Management's ENVX Position: Q4 2025 in Review

Prelude Capital Management sold out of Enovix (ENVX) in Q4 2025, closing a stake of 25,012 shares — an estimated $249K sold.

Prelude Capital Management first reported a position in ENVX in Q2 2022 and held it in 7 quarters. The position peaked at $437K in Q1 2023. 318 funds tracked by Wall St. Rank hold ENVX as of Q4 2025.

  • Prelude Capital Management reported no remaining Enovix position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 25,012 Enovix shares in Q4 2025, an estimated $249K.
  • Prelude Capital Management first reported a position in Enovix in Q2 2022 and held it in 7 quarters.
  • Prelude Capital Management's Enovix position peaked at $437K in Q1 2023.
  • 318 funds tracked by Wall St. Rank held Enovix as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.